Assistant Secretary Delphin-Rittmon will save lives and protect our families from the pain of overdoses and substance use disorder that is devastating our country. We look forward to standing with Dr. Delphin-Rittmon as she leads the federal response to build access to prevention, treatment, harm reduction, and recovery supports for all communities in need.

The crack-cocaine sentencing disparities have disproportionately and unjustly impacted communities of color and they must be eliminated. The current federal sentencing disparities lack evidence and have torn apart families through mass incarceration.

On May 28th, President Biden released his budget request for 2022, which would invest $41 billion in national drug control agencies. The budget devotes a historically high portion of resources to evidence-based treatment, harm reduction, prevention, and recovery services.

This June, End Substance Use Disorder recognizes the strength and resilience of LGBTQIA leaders in challenging discriminatory laws and creating a sense of belonging for all Americans, regardless of who we love. We call on lawmakers to act this Pride Month and protect our LGBTQIA neighbors from violence, mental anguish, and discrimination. We all deserve peace of mind.

Overdose prevention programs deliver on their promise - they keep people who use drugs safe and provide pathways to treatment. This modest investment in our nation’s overdose prevention infrastructure will save lives, prevent the spread of infectious diseases, and reduce health care costs.

Today, End Substance Use Disorder signed on to a set of guiding principles for how states, cities, and counties should use funds received from opioid manufacturers, pharmaceutical distributors and pharmacies as a result of litigation brought against these companies for their role in the opioid epidemic that has claimed more than half a million lives over the past two decades.

We must address our children’s suffering and promote their healing by providing immediate access to evidence-based care. Identifying behavioral health conditions early is a proven way to prevent substance use disorder in adolescence and adulthood.

Today, the U.S. House passed the Fairness in Orphan Drug Exclusivity Act (H.R. 1629). The bill will help expand access to generic medications to treat opioid use disorder and other medical conditions.

What we need are comprehensive solutions, rooted in evidence and equity, that remove discriminatory barriers to treatment and that provide long-term sustainable funding for critical support and services.

In a hearing on Capitol Hill today, Secretary of Health and Human Services Xavier Becerra called for Congress to expand access to buprenorphine, a life-saving overdose prevention medication.

Earlier today, ‘End Substance Use Disorder’ led a coalition of 120 leading organizations in delivering a letter to Congress urging the swift passage of the Mainstreaming Addiction Treatment Act (MAT Act).

Today, the U.S. Senate held a hearing on “Examining Our COVID-19 Response: Using Lessons Learned to Address Mental Health and Substance Use Disorders.”

Today, the Biden Administration took a significant step to address the worsening overdose crisis. The administration issued regulatory guidelines that will remove certain barriers to prescribing buprenorphine, a medication that can help save people from deadly overdoses.

End Substance Use Disorder stands with George Floyd’s family in calling for the Senate to pass the George Floyd Justice in Policing Act. End Substance Use Disorder was founded to ensure that our laws reflect our values of human dignity and equal opportunity. We can fulfill our mission only if we face the realities about race and privilege in our country.

Today, End Substance Use Disorder President Erin Schanning joined Rep. Andy Kim (D-NJ) in calling for the elimination of federal barriers that prevent patients with opioid use disorder from accessing lifesaving treatment.

End Substance Use Disorder issued a statement of support for a hearing on Capitol Hill in favor of the Mainstreaming Addiction Treatment Act.

Today, End Substance Use Disorder issued a report that summarizes the research on when healthcare providers opt out of prescribing buprenorphine and why they choose not to prescribe the medication to people with opioid use disorder. The report then provides policy solutions to ensure that every American with opioid use disorder can access buprenorphine.

Throughout his career, Secretary Walsh has spoken openly and with compassion about his struggles with substance use disorder, the support he received from his community, and his pathway to recovery.